EPCAM and cancer: Genetic alteration and morphological changes are modulated during cancer metastasis, such as loss of epithelial cell identity (e.g., occludin and EpCAM) and acquisition of mesenchymal features (e.g., vimentin and TWIST1) [1]–[3], [27].